The Valley Desk

NCT00678587 · Interventional trial

Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures

Overall registry status Terminated

Phase 3

Conditions Chronic Liver Disease, HBV, HCV, HIV Infection, Hepatitis B Virus, Hepatitis C Virus, Human Immunodeficiency Virus, Liver Diseases, NASH - Nonalcoholic Steatohepatitis, Non-alcoholic Steatohepatitis, Thrombocytopenia

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov